Guidewell and Highmark Ventures led a $35 million funding round for Healthmap, a kidney population health management company, joining other investors such as Windrose, DCHP and Shulman Ventures, who contributed to previous funding rounds, Healthcare Finance reports.
GuideWell is the parent of Florida Blue and Triple-S Management, the Blue Cross Blue Shield plans of Florida and Puerto Rico, while Highmark and its Blue-branded affiliates cover members in Pennsylvania, Delaware, West Virginia and New York.
The Blue-affiliated plans said they made the investment to highlight what they consider a growing public health imperative: to more effectively identify and care for the 40 million people living with kidney disease in the U.S. Read more.
